Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: Rationale for immune checkpoint blockade Journal Article


Authors: Jelinic, P.; Ricca, J.; Van Oudenhove, E.; Olvera, N.; Merghoub, T.; Levine, D. A.; Zamarin, D.
Article Title: Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: Rationale for immune checkpoint blockade
Abstract: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a highly aggressive monogenic cancer driven by SMARCA4 mutations. Here, we report responses to anti-PD1 immunotherapy in four patients and characterize the immune landscape of SCCOHT tumors using quantitative immunofluorescence and gene expression profiling. Unexpectedly for a low mutation burden cancer, the majority of the tumors (eight of 11 cases) demonstrated PD-L1 expression with strong associated T-cell infiltration (R-2 = 0.60-0.95). PD-L1 expression was detected in both tumor and stromal cells, with macrophages being the most abundant PD-L1-positive cells in some tumors (three of 11 cases). Transcriptional profiling revealed increased expression of genes related to Th1 and cytotoxic cell function in PD-L1-high tumors, suggesting that PD-L1 acts as a pathway of adaptive immune resistance in SCCOHT. These findings suggest that although SCCOHT are low-mutational burden tumors, their immunogenic microenvironment resembles the landscape of tumors that respond well to treatment with PD-1/PD-L1 blockade.
Keywords: pd-1; expression; lung-cancer; association; tumor-infiltrating lymphocytes; blockade; number; nivolumab; smarca4 mutations; neoantigen load; instable endometrial cancers
Journal Title: JNCI: Journal of the National Cancer Institute
Volume: 110
Issue: 7
ISSN: 0027-8874
Publisher: Oxford University Press  
Date Published: 2018-07-01
Start Page: 787
End Page: 790
Language: English
ACCESSION: WOS:000445380200016
DOI: 10.1093/jnci/djx277
PROVIDER: wos
PMCID: PMC6037122
PUBMED: 29365144
Notes: Article -- djx277 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Taha Merghoub
    364 Merghoub
  2. Dmitriy Zamarin
    201 Zamarin
  3. Jacob M Ricca
    16 Ricca